Effects of Withania somnifera (L.) Dunal in acute pulmonary pathophysiology in a rat model of smoke-induced lung injury and role of IRS-1 and SOX-2

Abstract

The respiratory structure has a broad capacity to undergo the mechanism of regeneration. The recent study was intended to determine the efficacy of Withania somnifera (L.) Dunal and expression levels of IRS-1 and SOX-2 genes in the smoke-induced Pulmonary Injury. The present study included 3 groups (n = 9): Normal/negative control (NC), positive control/disease control (PC), and treatment group (TG; treated orally with 350 mg/kg of ethanol extract). Lung injury was induced in PC and TG groups in rats by cigarette smoke (4 CG/day). Decapitation (n = 3) was done on the 14th, 18th, and 21st day of treatment. Phenolic acid quantification by HPLC-UV/VIS showed a significant concentration of p-coumaric acid (130.2 mg/kg) that may also contribute to the extract's efficacy. Hematological parameters (leukocytes, hemoglobin, hematocrit) and serum oxidative parameters (total oxidant status and malondialdehyde) were significantly improved (P ≤ 0.05) in the TG compared to the PC group. Moreover, the total antioxidant capacity, total plasma protein, albumin, globulin, and platelet count significantly decreased in the PC while increasing in the treatment group (P ≤ 0.05). Histology showed damaged histological structures in the PC group, while there was obvious regeneration of architectural damage in the TG group. The IRS-1 and SOX-2 genes were up-regulated in the PC group, indicating the role of IRS-1 and SOX-2 gene expression in tissue homeostasis and regeneration in smoke-induced Pulmonary Injury. These results rationalize the traditional use of W. somnifera in pulmonary diseases and encourage further studies to exploit it in the pharmaceutical industry.